SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001558370-24-007715
Filing Date
2024-05-10
Accepted
2024-05-10 10:37:44
Documents
69
Period of Report
2024-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q krbp-20240331x10q.htm   iXBRL 10-Q 1328154
2 EX-31.1 krbp-20240331xex31d1.htm EX-31.1 23256
3 EX-31.2 krbp-20240331xex31d2.htm EX-31.2 27519
4 EX-32.1 krbp-20240331xex32d1.htm EX-32.1 7745
5 EX-32.2 krbp-20240331xex32d2.htm EX-32.2 7875
  Complete submission text file 0001558370-24-007715.txt   6197721

Data Files

Seq Description Document Type Size
6 EX-101.SCH krbp-20240331.xsd EX-101.SCH 43553
7 EX-101.CAL krbp-20240331_cal.xml EX-101.CAL 38004
8 EX-101.DEF krbp-20240331_def.xml EX-101.DEF 187534
9 EX-101.LAB krbp-20240331_lab.xml EX-101.LAB 389802
10 EX-101.PRE krbp-20240331_pre.xml EX-101.PRE 312778
73 EXTRACTED XBRL INSTANCE DOCUMENT krbp-20240331x10q_htm.xml XML 1054773
Mailing Address 7707 FANNIN ST. SUITE 140 HOUSTON TX 77054
Business Address 7707 FANNIN ST. SUITE 140 HOUSTON TX 77054 832-968-4888
Kiromic Biopharma, Inc. (Filer) CIK: 0001792581 (see all company filings)

IRS No.: 464762913 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-39619 | Film No.: 24933318
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)